AbCellera receives $175.6 mn from Canada for coronavirus research
By Akshay Kedari  Date: 2020-05-04

AbCellera receives $175.6 mn from Canada for coronavirus research

Healthcare companies are racing against time to develop a vaccine for COVID-19 which has killed thousands of people across the world. Given the dire situation, healthcare companies are seeking financial support from governments and philanthropists for developing novel COVID-19 treatments and vaccines.

A similar incident comes into light when AbCellera Biologics Inc., the Canada-based biotechnology firm, has received a financial commitment of up to USD 175.6 from the Canadian Government for accelerating efforts to develop novel therapies to treat COVID-19. The company is also expected to use this funding to develop cutting-edge technologies and manufacturing facilities for antibody treatment against future pandemic threats.

Sources cite that the company is using its antibody discovery platform to study blood samples of patients who have recovered from coronavirus disease. In collaboration with VRC (Vaccine Research Centre) at the National Institute of Allergy and Infection Diseases, the company has identified more than 500 unique human anti-SARS-CoV-2 antibodies. These antibodies may also be used to develop novel diagnostic tests to aid the medical community in monitoring COVID-19 spread.

Speaking on which, Navdeep Bains, Minister of Innovation, Science and Industry said that the Government of Canada is mobilizing its resources to confront COVID-19 and aiding the businesses and researchers that are working diligently to create novel therapies to tackle this pandemic. The funding would support AbCellera Biologicsto rapidly discover new solutions for COVID-19 while ensuring the nation’s long-term preparedness for future healthcare threats, Bains added.

Carl Hansen, Ph.D., CEO at AbCellera stated that the company is proud to have the support from the Canadian Government to rapidly find solutions to the ongoing pandemic.

As per sources, the company has received a financial commitment for funding under ISED’s (Innovation, Science and Economic Development) Strategic Innovation fund. With this initiative, the Government of Canada is aiming to support companies that are working on developing COVID-19 vaccines and critical medical supplies.

Source Credit - https://www.abcellera.com/news/2020-05-03

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Innovaccer unveils AI-enabled patient relationship management solution
Innovaccer unveils AI-enabled patient relationship management solution
By Akshay Kedari

Innovaccer, Inc., a healthcare company, has recently launched an AI (artificial intelligence) enabled patient relationship management solution. The new solution will streamline communication between the care teams and patients. In addition, the solu...

Geely Tech to rollout a smart battery swapping network across Jinan
Geely Tech to rollout a smart battery swapping network across Jinan
By Akshay Kedari

Geely Technology Group, a Chinese automobile manufacturer, and the Municipal Government of Jinan, China, have reportedly signed an all-round strategic cooperation deal to jointly develop a network of smart battery swapping service stations across Jin...

CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
By Akshay Kedari

Chinese biotechnology company, CStone Pharmaceuticals has recently announced that it has completed the Share Subscription Agreement with Pfizer Inc. for its newly issued shares worth US$200 million. The move furthers the biotech’s multifaceted ...

Researchers bag $6Mn grant to study the link between Parkinson’s & aging
Researchers bag $6Mn grant to study the link between Parkinson’s & aging
By Akshay Kedari

A three-year grant worth $6 million, funded by the Michael J. Fox Foundation, was recently awarded to a collaborative research team from Michigan’s Van Andel Institute (VAI) and the University of Minnesota Medical School. The grant was given th...

EY announces availability of OpsChain Network Procurement solution
EY announces availability of OpsChain Network Procurement solution
By Akshay Kedari

Ernst & Young (EY), a global professional services network, has recently announced the availability of a first-of-its-kind OpsChain Network Procurement solution. The solution has been built on the company’s OpsChain platform. It will enabl...